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A westernized high-fat diet (HFD) is associated with the development of inflammatory 
bowel disease (IBD). High-level fecal deoxycholic acid (DCA) caused by HFD contributes 
to the colonic inflammatory injury of IBD; however, the mechanism concerning the 
initiation of inflammatory response by DCA remains unclear. In this study, we sought to 
investigate the role and mechanism of DCA in the induction of inflammation via promoting 
NLRP3 inflammasome activation. Here, we, for the first time, showed that DCA dose-
dependently induced NLRP3 inflammasome activation and highly pro-inflammatory 
cytokine-IL-1β production in macrophages. Mechanistically, DCA-triggered NLRP3 
inflammasome activation by promoting cathepsin B release at least partially through 
sphingosine-1-phosphate receptor 2. Colorectal instillation of DCA significantly increased 
mature IL-1β level in colonic tissue and exacerbated DSS-induced colitis, while in vivo 
blockage of NLRP3 inflammasome or macrophage depletion dramatically reduced the 
mature IL-1β production and ameliorated the aggravated inflammatory injury imposed 
by DCA. Thus, our findings show that high-level fecal DCA may serve as an endogenous 
danger signal to activate NLRP3 inflammasome and contribute to HFD-related colonic 
inflammation. NLRP3 inflammasome may represent a new potential therapeutical target 
for treatment of IBD.
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inTrODUcTiOn
A westernized high-fat diet (HFD) is associated with the development of diverse inflammatory 
diseases, including inflammatory bowel disease (IBD). Epidemiological studies indicate that HFD 
consumption, as an important environmental factor, could increase the risk of both ulcerative colitis 
and Crohn’s disease (1, 2). Increasing evidence shows that prolonged exposure to the high level of 
fecal bile acids, which is caused by HFD, contributes to the occurrence of IBD and gastrointestinal 
cancer (3–5). Deoxycholic acid (DCA) makes up 58% of bile acid in human feces, and dietary fat 
is observed to mainly increase fecal secondary bile acids, especially DCA, which further increases 
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the concentration of colonic DCA (6, 7). Stenman and colleagues 
found that a diet high in fat increased the fecal concentration 
of DCA nearly 10-fold (7). Furthermore, high level of DCA, 
which is comparable to its concentration in feces of high-fat-fed 
mice could disrupt epithelial integrity and is related to barrier 
dysfunction (8, 9). Meanwhile, transient colorectal instillation of 
DCA in rat leads to mild colonic inflammation, whereas long-
term feeding of mice with a diet supplemented with DCA, which 
mimic the effect of a HFD, induces obvious colonic inflammation 
and injury that resembles human IBD (10, 11). These findings 
support the potential role of excessive fetal DCA in mediating 
colonic inflammatory injury of IBD; however, the mechanism 
concerning the initiation of inflammatory response by DCA 
remains largely unclear.
The innate immune system provides the first line to recognize 
microbes or endogenous molecules via pathogen-associated 
molecular patterns (PAMPs) or damage-associated molecular 
patterns (DAMPs) by host pattern recognition receptors (PRRs). 
Inflammasome is a major component of innate immunity, and 
recent studies have highlighted the critical role of NLRP3 inflam-
masome in the inflammatory response. NLRP3 inflammasome 
is a molecular platform that can be activated by multiple PAMPs 
or DAMPs and thus involved in diverse inflammatory diseases 
(12–14). Upon activation, NLRP3 recruits apoptosis-associated 
speck-like protein (ASC) and caspase-1 (interleukin-1 converting 
enzyme, ICE), leading to the maturation and secretion of highly 
pro-inflammatory cytokines, such as IL-1β (15). Unlike other 
cytokines, bioactive IL-1β production relies on inflammasome 
activation (16–18). More importantly, emerging evidences sug-
gest the pivotal role of NLRP3 inflammasome in the development 
and pathogenesis of IBD (19). Single nucleotide polymorphisms 
of nlrp3 gene have been linked to the development of Crohn’s 
disease (20). NLRP3 as well as caspase-1-deficient mice were 
protected from DSS-induced colitis (21, 22). Consistently, clini-
cal studies show increased IL-1β level in the serum and inflamed 
colonic tissues of IBD patients, and IL-1β levels are correlated well 
with the severity of intestinal inflammation and disease activity 
(23–26). Furthermore, pharmacological inhibition of IL-1β or 
Caspase-1 was shown to successfully ameliorate intestinal inflam-
mation in colitis animal models (27, 28).
Given the important role of the inflammasome in intestinal 
immunity, we hypothesized that NLRP3 inflammasome activa-
tion may be involved in the DCA-induced colonic inflammation. 
In this study, we provide evidence that DCA can activate NLRP3 
inflammasome and induce obvious mature IL-1β production in 
macrophages by promoting cathepsin B release at least partially 
via S1PR2 receptors. Colorectal instillation of DCA in mice 
strongly aggravates DSS-induced colitis and caspase-1 inhibition 
as well as macrophage depletion substantially alleviates colonic 
inflammation and injury.
MaTerials anD MeThODs
reagents
Lipopolysaccharide (LPS), DCA, CA-074 Me, N-acetyl-l-
cysteine (NAC), and JTE-013 were purchased from Sigma-
Aldrich (St. Louis, MO, USA). Poly (dA:dT) was obtained from 
Invivogen (San Diego, CA, USA). Nigericin was purchased from 
Cayman Chemical (Ann Arbor, MI, USA). Z-Guggulsterone was 
obtained from Santa cruz Biotechnology (Santa Cruz, CA, USA). 
VX-765 (belnacasan) was purchased from Selleck (Houston, TX, 
USA). 2′,7′-dichlorofluorescein diacetate (DCF-DA) was from 
Invitrogen/molecular probes. RPMI 1640, DMEM, and antibiot-
ics were obtained from Invitrogen (Carlsbad, CA, USA). ELISA 
Kits were purchased from eBioscience (San Diego, CA, USA).
Mice
The 6- to 8-week-old C57BL/6 female mice were purchased from 
Experimental Animal Center of the Chinese Academy of Sciences 
(Shanghai, China) and housed in a specific pathogen-free (SPF) 
facility. The animal study protocols complied with the Guide 
for the Care and Use of Medical Laboratory Animals issued by 
the Ministry of Health of China and approved by the Shanghai 
Laboratory Animal Care and Use Committee.
cells
The murine macrophage cell line J774A.1 was obtained from 
Type Culture Collection of the Institutes of Biomedical Sciences, 
Fudan University (Shanghai, China). J774A.1 cells were culti-
vated in DMEM culture medium (Invitrogen) supplemented 
with 10% fetal bovine serum (Gibico) and 1% penicillin/
streptomycin (Invitrogen) at 37°C with 5% CO2. Bone marrow-
derived macrophages (BMDMs) were isolated and cultured as 
described elsewhere (29). Briefly, bone marrow cells were har-
vested from femurs and tibiae of C57BL/6 mice. Cells were then 
cultured in DMEM supplemented with 10% FBS and 30% L929 
cell- conditioned medium (as a source of M-CSF) for 6–7 days. 
Adherent cells were used in the following experiments.
In Vitro Dca Treatment
J774A.1 cells or BMDMs were primed with 1 μg/ml LPS for 5 h 
before stimulation with DCA at different concentrations, then, 
supernatants (SNs) were harvested at indicated time points 
and the IL-1β level was determined by ELISA Kit (eBioscience) 
according to the manufacturer’s instructions. For some experi-
ments, various inhibitors (e.g., NAC, CA-074 Me) were added to 
the culture medium 30 min ahead of DCA treatment.
Salmonella infection
J774A.1 cells (1 × 106) were infected for 1 h with the Salmonella 
(1:100) and then cultured in fresh medium supplemented with 
gentamicin (100 μg/ml).
lysosome and cathepsin B imaging
Lipopolysaccharide-primed J774A.1 cells were incubated with 
or without DCA (100  μM, 24  h); then, the cells were stained 
with Lyso Tracker Green DND-26 (Invitrogen) or cathepsin B 
fluorogenic substrate z-Arg-Arg cresyl violet (Neuromics) for 1 h, 
followed by Hoechst staining for half an hour. Fluorogenic signals 
were captured by inverted fluorescence microscope (Leica).
reactive Oxygen species Measurement
Lipopolysaccharide-primed J774A.1 cells were treated with or 
without DCA (100 μM), and nigericin stimulation (20 μM) was 
3Zhao et al. Deoxycholic Acid Activates Inflammasome
Frontiers in Immunology | www.frontiersin.org November 2016 | Volume 7 | Article 536
regarded as positive control. ROS production was measured by 
using DCF-DA (Invitrogen) probes according to the manufac-
turer’s instructions. Briefly, cells were incubated with DCF-DA 
(15 μM) for 1 h at 37°C after DCA stimulation. Fluorescence was 
visualized directly under a fluorescence microscope.
icP-Oes assay
Lipopolysaccharide-primed J774A.1 cells (1 × 107) were treated 
with or without DCA (100 μM, 24 h); then, the cells were lysed in 
ultra pure nitric acid before microwave digestion and then diluted 
to 5% HNO3. Intracellular K+ was analyzed by using Perkin Elmer 
Optima 8000 ICP-OES Spectrometer. External K calibration was 
performed between 0 and 10 ppm.
Transfection of small interfering rna 
Oligonucleotides
J774A.1 cells in 6-well plates were transfected with NLRP3, 
TGR5 small interfering RNA, or scrambled siRNA by using 
TransIT-Jurkat (Mirus Bio, Madison, WI, USA), followed by 
LPS stimulation and DCA treatment (100 μM, 24 h). IL-1β in 
supernatant was measured by ELISA. RNA oligonucleotides 
sequences were as follows: NLRP3, forward 5′-GGC GAG ACC 
UCU GGG AAA ATT-3′ and reverse 5′-UUU UCC CAG AGG 
UCU CGC CTT-3′; TGR5, forward 5′-CUG GAA CUC UGU 
UAU CGC UTT-3′ and reverse 5′-AGC GAU AAC AGA GUU 
CCA GTT-3′.
Western Blot
J774A.1 cells were lysed by protein lysis buffer (Sigma) contain-
ing protease and phosphatase inhibitors (Theromo), and the 
cell culture supernatant was concentrated by acetone precipita-
tion. Cell lysates (50 μg) or concentrated supernatant proteins 
were resolved by SDS-PAGE, transferred to PVDF membranes 
(0.2  μm), and probed with antibodies against IL-1β (Cell 
Signaling Technologies), Caspase-1 (Santa Cruz, CA, USA), 
NLRP3 (R&D), TGR5 (Abcam), and β-actin (sigma). For the 
detection of cytosolic cathepsin B, cells were thoroughly washed 
and permeabilized with extraction buffer containing 50  μg/
ml digitonin for 15  min at 4°C to lyse the plasma membrane 
without disturbing the intracellular membranes. These cell 
lysates were then subjected to SDS-PAGE and immunoblotted 
for cathepsin B (Santa Cruz, CA, USA). Reactive signals were 
detected by ECL Western Blotting Substrate (Thermo Fisher 
Scientific, Waltham, MA, USA) and ChemiDoc™ XRS+ System 
(Bio-Rad).
cytosolic cathepsin B activity assay
Extraction of cytosolic protein was performed as described 
above and cathepsin B activity was determined by a fluorometric 
assay kit (ApexBio). Briefly, 50 μl of each sample (containing 
100 μg of total protein) was incubated with cathepsin B reaction 
buffer (50 μl) and substrate Ac-RR-AFC (10mM, 2 μl) at 37°C 
for 1 h, and free amino-4-trifluoromethyl coumarin (AFC) was 
measured through a fluorescence spectrophotometer with an 
excitation wavelength of 400  nm and an emission wavelength 
of 505 nm.
colitis induction and Treatment
Acute colitis was induced in C57BL/6 mice with 2.5% DSS 
(MP Biomedicals) dissolved in drinking water given ad libitum 
for 7  days. DSS-treated animals were randomly divided into 
three groups and received an enema of PBS, 4mM DCA (in 
PBS, 0.1  ml), or 4mM DCA plus intraperitoneal injection of 
caspase-1 inhibitor (belnacasan, 50  mg/kg/day), respectively, 
for seven consecutive days from day 1 of DSS treatment (n = 7 
in each group). Body weight was measured daily throughout the 
course of experiment. On day 8, mice were sacrificed and colon 
length was measured. The paraffin sections of colon tissues 
were stained with hematoxylin and eosin. A scoring system 
was applied to assess diarrhea and the presence of occult or 
overt blood in the stool. Colon homogenates were used for 
immunoblot analysis of mature IL-1β and assessment of MPO 
activity.
In Vivo Macrophages Depletion
To evaluate the role of macrophages in the colonic inflammation 
exacerbated by DCA, colitis was induced in C57BL/6 mice with 
2.5% DSS for 7 days as described above. Macrophages depletion 
was performed by intraperitoneal injection of 0.2 ml clodronate-
liposomes (www.clodronateliposomes.com, Netherlands) 4 days 
prior to DSS treatment and on days 0, 2, 4, and 6 during 
DSS  treatment as described elsewhere (30). Animals were 
randomly divided into five groups, including control group, 
DSS-treated group, DSS-macrophages depletion group, DSS-
treated plus DCA enema group and DSS-treated plus DCA 
enema-macrophages depletion group (n = 7 in each group). On 
day 8, mice were sacrificed for sample collection and analysis as 
mentioned above.
histological analysis
Colonic histological scoring was determined by inflammatory 
cell infiltration (0–3) and tissue damage (0–3) in a blinded 
manner. For tissue inflammation, increased numbers of inflam-
matory cells in the lamina propria were scored as 1, confluence 
of inflammatory cells extending into the submucosa as 2, and 
transmural extension of the infiltrate as 3. For tissue damage, dis-
crete lymphoepithelial lesions were scored as 1, mucosal erosions 
were scored as 2, and extensive mucosal damage and/or extension 
into deeper structures of the bowel wall were scored as 3. The 
combined histological score ranged from 0 to 6.
statistics
All results were expressed as mean ± SEM. Statistical significance 
was assessed by two-tailed Student’s t-test or one-way analysis 
of variance (ANOVA). Differences were considered statistically 
significant at p < 0.05.
resUlTs
Dca induces caspase-1 activation and 
il-1β Maturation in Macrophages
The NLRP3 inflammasome recognizes many endogenous 
materials as danger signals and triggers the release of strong 
FigUre 1 | Dca induces mature il-1β release from macrophages. (a) LPS-primed J774A.1 macrophages were treated with DCA (0, 50, 100, and 200 μM) 
for 24 h. Released IL-1β in culture medium was analyzed by ELISA. (B) LPS-primed J774A.1 macrophages were treated with DCA (100 μM) for different time 
courses. Released IL-1β was analyzed by ELISA. (c) Immunoblot analysis of mature IL-1β (mIL-1β, 17 kD), active caspase-1 (p20, 20 kD) in culture supernatants 
(SN) and precursors of IL-1β (pro-IL-1β), caspase-1 (pro-caspase-1), NLRP3, ASC in cell lysates of LPS-primed J774A.1 macrophages treated with DCA (100 μM) 
for 24 h. β-actin was regarded as a loading control. (D) ELISA analysis of IL-1β in supernatants from LPS-primed bone marrow-derived macrophages (BMDMs) 
treated with different dosage of DCA. **p < 0.01; ***p < 0.001. Error bars indicate SEM. Representative data from at least three independent experiments giving 
similar results are shown.
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pro-inflammatory cytokines including active IL-1β, thus 
contributing to diverse diseases as atherosclerosis, Alzheimer’s 
disease, and T2 diabetes (31, 32). Here, we hypothesized that 
DCA may also exert its inflammatory potential via activating 
inflammasomes. Therefore, LPS-primed murine macrophage 
cell line J774A.1 was treated with different dosage of DCA, and 
the result showed that IL-1β secretion was obviously induced 
in a dose- and time-dependent manner in response to DCA 
(Figures  1A,B). IL-1β maturation was further confirmed 
by the detection of cleaved IL-1β and active caspase-1 as 
assessed by western blotting (Figure  1C). Meanwhile, DCA 
also dose-dependently induced IL-1β maturation and secre-
tion in murine bone marrow-derived macrophages (BMDMs) 
(Figure  1D). Moreover, we treated macrophages with DCA 
after LPS challenge and observed that DCA stimulation did 
not significantly increase the pro-IL-1β, NLRP3, and ASC level 
(Figure  1C), and DCA alone had no obvious effect on pro-
IL-1β and NLRP3 expression either (data not shown). These 
data demonstrate that DCA could induce IL-1β maturation 
and release in macrophages through promoting inflammasome 
activation.
Dca activates the nlrP3 inflammasome
Caspase-1 activation is an essential step to produce and release 
of mature IL-1β during inflammasome activation (13, 14). Here, 
caspase-1 inhibitor (belnacasan) significantly impaired the IL-1β 
secretion induced by DCA (Figure  2A), indicating that DCA 
induces IL-1β maturation in a caspase-1-dependent manner. 
In order to investigate whether DCA can activate the NLRP3 
inflammasome, which is usually involved in caspase-1 activation 
induced by multiple danger signals, we knocked down the expres-
sion of NLRP3 by transfecting macrophages with siRNA specific 
for Nlrp3. We found that LPS-primed J774A.1 macrophages 
transfected with control siRNA produced large amounts of IL-1β 
upon DCA exposure. In contrast, macrophages transfected with 
Nlrp3 siRNA produced much less IL-1β in response to DCA 
or nigericin (Figure 2B; Figure S1 in Supplementary Material), 
indicating the requirement of NLRP3 for IL-1β processing. 
Meanwhile, Nlrp3 siRNA transfection had no effect on IL-1β 
production induced by Salmonella or poly(dA:dT) (Figure S1 in 
Supplementary Material). These results suggest that DCA at least 
partially activates the NLRP3 inflammasome, leading to the acti-
vation of caspase-1 and subsequent IL-1β maturation and release.
FigUre 2 | Dca activates the nlrP3 inflammasome. (a) LPS-primed J774A.1 macrophages were treated with DCA (100 μM) in the presence or absence of 
caspase-1 inhibitor belnacasan (10 μM). IL-1β in supernatants was analyzed by ELISA. (B) Control siRNA (siCTL) or Nlrp3 siRNA (siNlrp3)-transfected J774A.1 
macrophages were primed with LPS and then treated with DCA (100 μM) for 24 h. IL-1β in supernatants was analyzed by ELISA. Inset, immunoblot analysis of 
NLRP3 expression in siCTL or siNlrp3-transfected J774A.1 cells. ***p < 0.001. Error bars indicate SEM. The data shown are from three independent experiments.
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Dca-induced nlrP3 inflammasome 
activation requires cathepsin B release
Three major cellular events are regarded as common mecha-
nisms for the NLRP3 inflammasome activation, including 
potassium (K+) efflux, reactive oxygen species (ROS) formation, 
and cathepsin B leakage (33–36). To identify the upstream 
events involved in DCA-induced inflammasome activation, we 
observed the effect of selective inhibitors on IL-1β secretion in 
DCA-treated macrophages. DCA-induced IL-1β secretion was 
not suppressed by the inhibition of ROS formation and K+ efflux 
(Figures  3A,B), which was confirmed by the fact that DCA 
stimulation had no obvious effect on intracellular ROS forma-
tion and potassium level (Figure S2 in Supplementary Material); 
however, it was dramatically blunted by CA-074Me, a cathepsin 
B inhibitor (Figure 3C). Consistently, DCA treatment strongly 
decreased the staining of lysosomal cathepsin B (Figure  3D) 
and increased cytosolic cathepsin B level as well as its activity 
(Figures 3E,F), which indicated the release of cathepsin B into 
cytoplasm. Unexpectedly, lysosomes retained their morphology 
in DCA-treated cells (Figure 3D), implying the involvement of 
other mechanisms responsible for the DCA-induced cathepsin B 
release. These data suggest that DCA induces NLRP3 inflamma-
some activation mainly through promoting cathepsin B release.
Dca-induced cathepsin B release and 
il-1β Production are Mediated by 
sphingosine-1-Phosphate receptors 2
To better understand the molecular mechanism underlying the 
induction of NLRP3 inflammasome activation by DCA, the 
major bile acid nuclear receptor farnesoid X-receptor (FXR) 
and membrane receptor TGR5 were selectively inhibited (37). 
Unexpectedly, neither suppression of FXR nor knockdown 
of TGR5 expression had obvious effect on mature IL-1β 
production in response to DCA (Figures  4A,B; Figure S3 in 
Supplementary  Material), which indicated the involvement 
of other bile acid receptors. Sphingosine-1-phosphate recep-
tor 2 (S1PR 2), which belongs to G protein-coupled receptor 
(GPCR), is reported to be another kind of bile acid receptor that 
appears to play an important role in the regulation of hepatic 
lipid metabolism (38). Importantly, S1PR2 is found as the major 
S1PRs expressed in monocytes/macrophages and also has been 
required for mast cell degranulation and chemotaxis toward 
the site of inflammation (39), implying its important role in 
the immune regulation and inflammatory response. Here, we 
observed that S1PR2 antagonist JTE-013 could significantly 
inhibit IL-1β release upon DCA stimulation (Figure  4C); 
intriguingly, JTE-013 could dramatically prevent cathepsin B 
release from lysosome (Figures 4D–F), which is critical in the 
DCA-triggered NLRP3 inflammasome activation. These data 
strongly suggest that S1PR2 is a key mediator of NLRP3 inflam-
masome activation induced by DCA.
Dca administration exacerbates Dss-
induced colitis and caspase-1 inhibition 
exhibits significant Protective role
To investigate the effect of DCA and its inductive role of inflam-
masome activation in the development of colitis, DSS-treated 
mice received an enema of 0, 4mM DCA, or 4mM DCA plus 
intraperitoneal injection of caspase-1 inhibitor belnacasan. The 
addition of 4mM DCA enema caused much more severe colitis 
than DSS treatment alone, as evidenced by significant decrease 
of body weight and shortening of colon length (Figures 5A,B), 
much higher haematochezia score, and MPO activity 
(Figures  5C,D). Of note, the mature IL-1β level in colon tis-
sue is elevated dramatically in DCA enema group (Figure 5E), 
indicating the highly activation of inflammasome. Consistently, 
H&E staining of colonic tissue in DCA enema group showed sig-
nificantly higher mucosal inflammatory cell infiltration and more 
FigUre 3 | activation of nlrP3 inflammasome by Dca depends on cathepsin B release. (a) LPS-primed J774A.1 macrophages were treated with DCA 
in the presence or absence of NAC (10 mM) for 24 h. IL-1β in supernatants was analyzed by ELISA. (B) LPS-primed J774A.1 macrophages were treated with 
DCA in the presence or absence of KCL (140 mM) for 2 h. IL-1β in supernatants was analyzed by ELISA. (c) LPS-primed J774A.1 macrophages were treated with 
DCA in the presence or absence of CA-074Me (50 μM) for 24 h. IL-1β in supernatants was measured by ELISA. (D) LPS-primed J774A.1 macrophages were 
treated with or without DCA. The cells were incubated with Lyso Tracker (green) or cathepsin B (Cat B) substrate z-Arg-Arg-cresyl violet, which emits red signal 
upon cleavage by cathepsin B, followed by Hoechst staining (blue). (e,F) LPS-primed J774A.1 macrophages were treated with or without DCA, then, cytosolic 
protein was isolated for the immunoblot analysis of mature cathepsin B (e) as well as fluorometric assay of cathepsin B activity (F). **p < 0.01; ***p < 0.001. n.s., 
no statistically significant difference (p > 0.05). Error bars indicate SEM. The data shown are representative of three individual experiments.
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severe epithelial layer destruction compared to that of the DSS 
alone group (Figure  5F). Indeed, inhibition of caspase-1 with 
belnacasan obviously reduced the mature IL-1β level in colon 
tissue and largely prevented the deteriorating role of DCA in the 
DSS-induced colitis (Figures 5A–F). These data provide further 
evidence that induction of inflammasome activation is a major 
pathogenic mechanism of DCA in the colonic inflammation.
Macrophages Depletion abrogates the 
exacerbating role of Dca in the  
Dss-induced colitis
Since IL-1β is primarily produced by activated macrophages, we 
sought to study whether colonic macrophages are the major effec-
tors of DCA. Macrophage depletion was achieved by injection 
of clodronate-containing liposomes (CL), which can selectively 
cause macrophage apoptosis. Immunohistochemistry staining 
showed mucosal infiltration with large numbers of macrophages 
in DSS-treated, DCA enema mice, but not clodronate liposomes-
administrated counterparts (Figure S3 in Supplementary 
Material). Macrophage depletion almost abrogated the produc-
tion of mature IL-1β in colon tissues induced by DCA enema 
(Figure 6E) and significantly improved the clinical parameters 
of DSS-treated, DCA enema mice, showing less body weight 
decease and colon length shortening (Figures 6A,B), much lower 
haematochezia score, and MPO activity (Figures 6C,D), as well 
as less mucosal inflammatory cell infiltration and less disruption 
of the mucosal epithelium (Figure 6F). These data indicate that 
DCA exerts its pro-inflammatory effect mainly through colonic 
macrophages.
DiscUssiOn
High-fat diet affects bile acid metabolism, and dietary fat also 
changes fecal bile acid profile, characterized by substantial 
increase of DCA in feces, which may contribute to the patho-
genesis of IBD; however, the detailed mechanisms still need to 
be explored. In this study, we, for the first time, proved that DCA 
could dose-dependently induce NLRP3 inflammasome activa-
tion and highly pro-inflammatory cytokine-IL-1β production in 
macrophages. Knockdown of NLRP3 expression and caspase-1 
inhibition largely abrogated DCA-induced IL-1β secretion. 
In vivo experiments showed that colorectal instillation of DCA at 
the concentration comparable to HFD significantly exacerbated 
DSS-induced colitis, as evidenced by substantial decrease of body 
weight, increased histological colitis severity, and importantly, 
pronounced elevation of mature IL-1β level in colon tissue. 
Furthermore, blockage of NLRP3 inflammasome activation or 
macrophage depletion obviously reduced the mature IL-1β level 
and protected mice from the aggravated inflammation imposed 
by DCA. Together, our results provide a new mechanism that 
FigUre 4 | Dca-induced cathepsin B release and il-1β secretion is mediated by s1Pr 2. (a) LPS-primed J774A.1 macrophages were treated with DCA in the 
presence or absence of Z-Guggulsterone (20 μM). IL-1β in supernatants was analyzed by ELISA. (B) Control siRNA (siCTL) or TGR5 siRNA (siTGR5)-transfected 
J774A.1 macrophages were primed with LPS and then treated with DCA. IL-1β in supernatants was analyzed by ELISA. Inset, immunoblot analysis of TGR5 expression 
in siCTL or siTGR5-transfected J774A.1 cells. (c) LPS-primed J774A.1 macrophages were treated with DCA in the presence or absence of JTE-013 (10 μM). IL-1β in 
supernatants was analyzed by ELISA. (D) LPS-primed J774A.1 macrophages were treated with DCA in the presence or absence of JTE-013. The cells were incubated 
with cathepsin B substrate followed by Hoechst staining. (e,F) LPS-primed J774A.1 macrophages were treated with DCA in the presence or absence of JTE-013, and 
cytosolic protein was isolated for the immunoblot analysis of mature cathepsin B (e) as well as fluorometric assay of cathepsin B activity (F). ***p < 0.001; n.s., no 
statistically significant difference (p > 0.05). Error bars indicate SEM. The data shown are representative of three individual experiments giving similar results.
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high level DCA caused by HFD contributes to colonic inflamma-
tion through activating NLRP3 inflammasome.
NLRP3 inflammasome, as the most extensively studied inflam-
masome, can be activated by diverse stimuli, including bacterial 
toxins, small molecules, as well as various crystals, many of which 
are host-derived components, such as uric acid, fatty acid, and 
ATP; here, we demonstrated that secondary bile acid DCA can 
also activate NLRP3 inflammasome. Despite the structure and 
characteristic of different stimuli diverse, potassium (K+) efflux, 
cathepsin B leakage from lysosomes, and ROS production are 
the three common mechanisms of NLRP3 inflammasome activa-
tion (33–36). The data obtained in our study demonstrated that 
NLRP3 inflammasome activation by DCA requires cathepsin B 
leakage. Numerous studies have shown that cathepsin B leakage 
usually occurs in the crystal-induced inflammasome activation, 
such as silica and uric acid crystals (40, 41), accompanied with 
lysosomal disruption. However, we found that phagocytic uptake 
was not required for DCA-induced IL-1β secretion (data not 
shown), and there was no evidence of lysosome damage either, 
thus indicating the involvement of other mechanisms responsible 
for the DCA-induced cathepsin B release. Further evidence 
showed that, instead of the major bile acid receptors (nuclear 
receptor FXR and membrane receptor TGR5), another kind of 
GPCR S1PR2 (also known as a bile acid receptor) participated 
in the DCA-induced IL-1β secretion. In line with our findings, 
S1PR2 was observed to modulate pro-inflammatory cytokine 
production (including IL-1β) in bone marrow cells and affect 
osteoclastogenesis, thus plays an essential role in inflammatory 
bone loss diseases (42). In addition, Skoura and colleagues 
proved that S1PR2 expressed in macrophages of atherosclerotic 
plaque regulates inflammatory cytokine secretion (IL-1β, IL-18) 
and promotes atherosclerosis (43). Our finding that S1PR2 
antagonist dramatically prevented cathepsin B release induced 
by DCA confirms the role of S1PR2 in mediating NLRP3 inflam-
masome activation and IL-1β secretion. Therefore, different from 
the endocytosed crystals, DCA-induced cathepsin B release may 
be receptor-mediated, although the intermediate process needs 
further investigation. Blocking S1PR2 signaling might be a novel 
therapeutic strategy to the HFD-related inflammatory diseases 
such as atherosclerosis and IBD.
FigUre 5 | Dca administration aggravates Dss-induced colitis and caspase-1 antagonist protects mice from severe colon inflammation. (a) Loss of 
basal body weight, (B) colon length, (c) haematochezia score, and (D) MPO activity in colon tissue of control, DSS-treated, DSS-treated plus DCA enema, 
DSS-treated plus DCA enema, and belnacasan-injection mice (caspase-1 antagonist, 50 mg/kg/day). (e) Immunoblot analysis of mature IL-1β (17 kD) in colonic 
homogenates, (F) H&E staining and histological score of distal colon sections of differently treated mice as described above. **p < 0.01; ***p < 0.001 compared to 
the DSS-treated alone mice. #p < 0.05; ##p < 0.01; ###p < 0.001 compared to the DSS-treated plus DCA enema mice. Error bars indicate SEM. The data shown are 
from three independent experiments.
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A very recent report exhibited by Guo and colleagues (44) 
showed that opposite to our findings, bile acids conveyed an 
inhibitory effect on NLRP3 inflammasome activation. In this 
report, they demonstrated that bile acids inhibited NLRP3 
inflammasome activation via the TGR5-cAMP-PKA axis, 
whereas our data showed that DCA triggered NLRP3 inflam-
masome activation through S1PR2-cathepsin B pathway, one 
possible explanation of the discrepancy is that bile acids may 
have dual regulatory effect on inflammasome activation by dif-
ferent mechanisms. The distinct modulation effect of bile acids 
on inflammasome activation may depend on diverse factors, such 
as bile acid concentration, receptors involved, and the presence 
or absence of other inflammasome activators. Guo et al. proved 
that bile acids at their physiological concentrations exhibited 
suppressive effect on inflammasome activation, while our find-
ings suggested that high-level DCA served as a danger signal and 
contributed to inflammasome activation, which is paralleled with 
the situation that excessive DCA induced by HFD exacerbated 
colitis. In addition, the presence or absence of other inflamma-
some stimuli (such as nigericin, ATP) could be another crucial 
factor. Similar to the dual effect of bile acids, epinephrine and 
norepinephrine inhibited cytokine production (IL-1β, IL-6, and 
TNF-α) in the presence of pro-inflammatory stimuli, otherwise 
increased such cytokine production through β2 adrenergic recep-
tor (β2AR) (45). Taken together, although the accurate regulation 
mechanisms of bile acids on inflammasome activation still need 
to be explored, the role of bile acids may be a double-edged sword 
and their in vivo concentrations should be tightly controlled.
Our in  vivo studies showed that DCA instillation at a high 
concentration, which comparable to the concentration on a HFD 
(7), significantly exacerbated DSS-induced colitis. These results 
are consistent with previous report that a DSS-induced chronic 
ulcerative colitis model showed mild inflammatory manifesta-
tions and became more aggravated when HFD was administered 
(46). In our model, DSS affects the epithelial barrier first, which 
allowing translocated bacteria endotoxin (e.g., LPS) to stimulate 
lamina propria macrophages and provide the first signal for the 
synthesis of pro-IL-1β, and subsequently excessive DCA triggers 
NLRP3 inflammasome activation and promotes bioactive IL-1β 
secretion, thus contributing to intestinal inflammatory response. 
These results offer a new explanation for the aggravated inflam-
matory injury in individuals consuming HFD, who have already 
suffered from intestinal barrier dysfunction, for example, high 
meat intake was reported to correlate with increased likelihood 
FigUre 6 | Depletion of colonic macrophages dramatically reduced the severe inflammation and tissue injury superimposed on Dss-treated mice 
by Dca. Clodronate-containing liposomes (CL) was used to eliminate colonic macrophages. (a) Loss of basal body weight, (B) colon length, (c) haematochezia 
score, and (D) MPO activity in colon tissue of control, DSS-treated, DSS-CL, DSS-treated plus DCA enema, and DSS-treated plus DCA enema-CL mice. (e) 
Immunoblot analysis of mature IL-1β (17 kD) in colonic homogenates (F) H&E staining and histological score of distal colon sections of differently treated mice as 
described above. *p < 0.05; **p < 0.01; ***p < 0.001 compared to the DSS-treated alone mice. #p < 0.05; ##p < 0.01; ###p < 0.001 compared to the DSS-treated 
plus DCA enema mice. Error bars indicate SEM. Representative data from three independent experiments are shown.
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of UC relapse (47). In another aspect, numerous in  vitro and 
ex  vivo studies show that high level DCA is toxic to epithelial 
cells and able to disturb intestinal permeability; meanwhile, mice 
fed with a diet supplemented with DCA for 10 weeks to mimic 
HFD exhibits impaired gut barrier function (9), and these find-
ings indicate that long-term exposure to excessive DCA alone can 
cause intestinal barrier dysfunction and increase the passage of 
both LPS and DCA into gut mucosa, which may result in the 
initiation of inflammation at least partially via inflammasome 
activation. It is of certainty that there should be many other fac-
tors involved in HFD-induced colitis, including intestinal flora, 
which also affect bile acids metabolism by increasing secondary 
bile acids level (such as DCA). The contribution of the interaction 
between bile acids and intestinal bacteria to the development of 
HFD-induced colitis remains to be further investigated.
Collectively, our findings disclose that excessive DCA 
serves as an endogenous danger signal to activate NLRP3 
inflammasome in macrophages and exacerbates colonic 
inflammation. Additionally, increased fecal DCA has also been 
implicated in the promotion of colon tumorigenesis. DCA was 
observed to induce colonic crypt cells proliferation and related 
to colon cancer growth and progression (48–50). Since chronic 
uncontrolled inflammation in the intestine is closely related to 
the development of colitis-associated cancer (CAC), our findings 
here suggest another possible mechanism that DCA participates 
in the development of colon cancer. In summary, our study offers 
a plausible mechanistic basis by which HFD might increase the 
prevalence of colitis and suggests the change of lifestyle to prevent 
HFD-related inflammatory diseases like IBD.
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